Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

10

Number of overlapping holdings

16.4%

% of BBP's 65 holdings also in LFSC

32.3%

% of LFSC's 31 holdings also in BBP

Overlap by Weight
Sector Drift (BBP minus LFSC)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in BBP
Weight
in LFSC
Overlap
TRAVERE THERAPEUTICS, INC. 2.0% 3.8% 2.0%
ACADIA PHARMACEUTICALS INC 1.9% 2.2% 1.9%
INSMED INC 1.8% 6.0% 1.8%
UNITED THERAPEUTICS CORP 1.7% 2.6% 1.7%
INTRA-CELLULAR THERAPIES INC 1.7% 6.0% 1.7%

Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to LFSC
MIRUM PHARMACEUTICALS, INC. 2.4%
ALNYLAM PHARMACEUTICALS INC 2.1%
LIGAND PHARMACEUTICALS-CL B 1.9%
LEXICON PHARMACEUTICALS, INC. 1.9%
LEGEND BIOTECH CORPORATION SPONSORED 1.9%
BIOCRYST PHARMACEUTICALS INC 1.8%
IONIS PHARMACEUTICALS, INC. 1.8%
DAY ONE BIOPHARMACEUTICALS, INC. 1.8%
TG THERAPEUTICS INC 1.8%
ADMA BIOLOGICS, INC. 1.8%
BBP Underweight Relative to LFSC
RADNET INC -8.8%
WAVE LIFE SCIENCES LTD. -6.0%
LIVANOVA PLC -5.9%
MERIT MEDICAL SYSTEMS INC -5.3%
NEOGENOMICS INC -4.9%
SOLENO THERAPEUTICS INC -4.4%
COLLEGIUM PHARMACEUTICAL, INC. -4.3%
INTRA-CELLULAR THERAPIES INC -4.3%
INSMED INC -4.3%
BLUEPRINT MEDICINES CORP. -4.2%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY